United States: FDA Moves Forward On Laboratory Developed Tests While Stakeholders And Congress Weigh Next Steps - Crowell & Moring LLP

Digital health companies, investors, and other healthcare organizations should follow policy developments with a strategic lens towards their market opportunities for key potential growth and risk